Stocks in play: Kits Eyecare Ltd.
Is reporting its results for the first quarter ended March 31, 2023. Revenue increased 38% to a record $27.7 million compared to $20.1 million. Net loss improved to $1.0 million compared to a net loss of $2.3 million. EBITDA improved by $1.7 million to $(0.0) million compared to $(1.7) million. Kits Eyecare Ltd. shares T.KITS are trading unchanged at $5.17.
Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.
